Le Vet. Pharma specialises in registering novel veterinary pharmaceuticals. After acquiring marketing authorisations for said products, we focus on driving sales through a network of carefully selected distributors. Most of our partners are Europe based, but we also do business in countries such as Australia, Canada, South Korea and New Zealand. On top of that, due to a close collaboration with AST Farma in the Netherlands, we are able to provide direct access to the Dutch veterinary market.
Born out of a family business, we take a personal approach to provide clients with sales and marketing support, ranging from customisable packaging to research reports as well as internationally adoptable marketing materials.
Le Vet. Pharma was founded in 2002 and started business with Clavubactin: the first generic veterinary medicinal product with amoxicillin and clavulanic acid as the active substances.
Le Vet. Pharma excels in making things possible. for distributors, manufacturers and veterinarians worldwide.
Our company has currently obtained over 85 registrations in more than 35 countries. But we do not intend to stop here. There are several interesting products in our pipeline that should be hitting the market in the near future. Please refer to the registration section of this website for an overview of our current portfolio.